US prostate cancer news: screening guidelines get major update
The latest of my "30 articles in one month" series to raise money for prostate cancer research covers news of updated guidelines for prostate cancer screening in the US.
![]() |
| American Cancer Society announces new prostate cancer screening guidelines |
[Note: I pledged to produce 30 articles in one month, even though I'm currently undergoing prostate cancer treatment, to achieve a fundraising goal. Please consider donating here and sharing a link to this blog (CobbsBlog.com) on social media.]
As a public health issue, prostate cancer (PCa), has grown rapidly this century and is now comparable in scale to breast cancer (BCa). By some key numerical measures PCa has now overtaken BCa, for example in terms of UK deaths, recent UK diagnoses, and projected US new cases. The American Cancer Society has projected 333,830 new prostate cancer cases in 2026. Screening men for early signs of prostate cancer can reduce the death toll and the impact of treatment.
Good news! Major improvements in US prostate cancer screening guidelines
I'm genuinely excited that the American Cancer Society chose this month, November, 2026 to announce major changes to its prostate cancer screening guidelines, intended to improve detection and treatment of a disease that is projected to result in 33,000 deaths in the US this year.
There is an excellent article about the changes in The Conversation, which interviewed Dr. Andrew Wolf, a physician at the University of Virginia who was one of the lead authors of the new guidelines. He walks readers through the changes and why they were made.
A fundamental change is a call for proactive screening for prostate cancer. Instead of just recommending that people talk with their healthcare provider to decide whether or not screening is right for them, the new recommendation is urging doctors to act, based on factors like age and a person’s risk of developing prostate cancer. For example, for people at average risk of developing prostate cancer:
we recommend they be screened with the prostate-specific antigen, or PSA, blood test every two years from age 50 through 69.
(If that level of screening were to be adopted universally, in American and beyond, many prostate cancer deaths would be avoided and millions of men would stand a better chance of avoiding the suffering caused by late intervention and treatment.)
More specifically, the new recommendation for people at higher risk, including Black men and men with a strong family history of prostate cancer, is that they should be screened annually from age 45 to 69.
A strong family history is defined as having a family member who was diagnosed with prostate cancer before age 65, or multiple family members diagnosed at any age.
Furthermore, "people with a single family member diagnosed at age 65 or older should be screened every two years from age 45 years to age 69 years."
The article goes on to explain why the changes were made and what the current views are on the risks of prostate cancer. The full 36-page guidelines document is available here. I strongly recommend reading the account in The Conversation,
In my article about PSA testing I mentioned that I would address arguments about prostate cancer screening. I'm not going to do that here. However, I do need to point out that there are considerable differences between countries on this topic, due in part to the way those countries are structured.
For example, if you have a national universal healthcare system (e.g. England), then screening guidelines for health-related issues can become requirements that must be funded. However, if you don't have a national universal healthcare system (e.g. USA), then medical guidelines are more aspirational, as in "this is what we hope will happen" versus "here's what has to happen by law."
I explained the way these differences manifest themselves in the the implementation of cancer screening guidelines in this article.
P.S. I love the fact that the image at the top of the article, a screenshot of the American Cancer Society page announcing the changes to prostate cancer screening guidelines, features happy women. It reminds me of the conversation I overheard on day at the cancer treatment centre where I got my radiotherapy. Two women were talking, the receptionist and a woman who had brough her husband in for treatment, and they were strongly agreeing with each other that "every man should be screened, just like everyone with breasts is screened."





